| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |